Drug Trend Reports
Read the latest information re: the opioid crisis.
Available in both English and French
Insights from 2023 Mid-Year Review Analysis Using Drug Checking and Harm Reduction Data
Understanding the trends and implications of Xylazine in Canada’s unregulated drug supply market
A comparative analysis from November 2022 to January 2023